Marex Group Plc (NASDAQ: MRX): Hunting Genuine Value In Market Debris

Currently, there are 70.29M common shares owned by the public and among those 30.61M shares have been available to trade.

The company’s stock has a 5-day price change of -0.94% and 9.84% over the past three months. It has a 12-month low price of $18.13 and touched a high of $40.96 over the same period. MRX has an average intraday trading volume of 657.54K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.06%, 3.33%, and 27.95% respectively.

Institutional ownership of Marex Group Plc (NASDAQ: MRX) shares accounts for 37.85% of the company’s 70.29M shares outstanding.

It has a market capitalization of $2.64B and a beta (3y monthly) value of 0.45. The stock’s trailing 12-month PE ratio is 13.63, while the earnings-per-share (ttm) stands at $2.72. The company has a PEG of 1.21 and the debt-to-equity ratio at 6.28. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.17% over the week and 6.51% over the month.

Analysts forecast that Marex Group Plc (MRX) will achieve an EPS of 0.9 for the current quarter, 0.83 for the next quarter and 3.81 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.88 while analysts give the company a high EPS estimate of 0.88. Earnings per share for the fiscal year are expected to increase by 11.44%, and 11.47% over the next financial year.

Looking at the support for the MRX, a number of firms have released research notes about the stock. HSBC Securities stated their Hold rating for the stock in a research note on March 10, 2025, with the firm’s price target at $33-$36. HSBC Securities coverage for the Marex Group Plc (MRX) stock in a research note released on November 21, 2024 offered a Buy rating with a price target of $33. Citigroup was of a view on November 06, 2024 that the stock is Buy, while UBS gave the stock Buy rating on May 20, 2024, issuing a price target of $27. Piper Sandler on their part issued Overweight rating on May 20, 2024.

Most Popular

Related Posts